deucravacitinib
bms
[' psa', 'psoriasis', 'deucra']
the psoriasis hub will be covering the following sessions today: safety and efficacy of deucravacitinib the impact of second-line therapeutic on disease control in patients with psa and more! stay tuned for updates throughout the day.
#acr22 #medicalcongress #psoriasis 
The Psoriasis and Psoriatic Arthritis Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education.